Nurix Therapeutics, Inc.

10-Q Quarter ended 2026-05-31 Jul 9, 2026 8-K Results of operations (earnings release) Jul 9, 2026 8-K Regulation FD disclosure; Other events Jun 11, 2026 8-K Entered a material agreement; Regulation FD disclosure Jun 8, 2026 8-K Shareholder vote results May 15, 2026 10-Q Quarter ended 2026-02-28 Apr 8, 2026 8-K Results of operations (earnings release) Apr 8, 2026 8-K Other events Mar 6, 2026 10-K Fiscal year ended 2025-11-30 Jan 28, 2026 8-K Results of operations (earnings release) Jan 28, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure; Other events Dec 9, 2025 8-K Director or officer change Nov 10, 2025 8-K Other events Oct 22, 2025 8-K Regulation FD disclosure; Other events Oct 22, 2025 10-Q Quarter ended 2025-08-31 Oct 9, 2025 8-K Results of operations (earnings release) Oct 9, 2025 8-K Regulation FD disclosure Sep 3, 2025 8-K Director or officer change Aug 22, 2025 10-Q Quarter ended 2025-05-31 Jul 9, 2025 8-K Results of operations (earnings release) Jul 9, 2025 8-K Regulation FD disclosure; Other events Jun 12, 2025 8-K Shareholder vote results May 19, 2025 10-Q Quarter ended 2025-02-28 Apr 8, 2025 8-K Results of operations (earnings release) Apr 8, 2025 8-K Director or officer change Mar 13, 2025 10-K Fiscal year ended 2024-11-30 Jan 28, 2025 8-K Results of operations (earnings release) Jan 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Other events Oct 31, 2024 8-K Director or officer change Oct 16, 2024 10-Q Quarter ended 2024-08-31 Oct 11, 2024 8-K Results of operations (earnings release) Oct 11, 2024 8-K Regulation FD disclosure Sep 5, 2024 10-Q Quarter ended 2024-05-31 Jul 11, 2024 8-K Results of operations (earnings release); Other events Jul 11, 2024 8-K Regulation FD disclosure; Other events Jun 17, 2024 8-K Shareholder vote results May 21, 2024 8-K Entered a material agreement; Other events Apr 12, 2024